Skip to main content

CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP

Written by Customer Service on . Posted in Public Companies.

CHEYENNE, Wyo., Jan. 21, 2026 (GLOBE NEWSWIRE) — CS Diagnostics Corp. (OTCQB: CSDX) today detailed its multi-channel sales strategy, global logistics partnerships, and sustainability roadmap supporting the commercial rollout of MEDUSA SDP.

MEDUSA SDP

The Company plans to distribute MEDUSA SDP through a diversified sales model designed to serve both institutional and consumer demand.

B2B distribution channels include:

  • Hospitals and healthcare facilities
  • Gyms and wellness centers
  • Schools and educational institutions
  • Corporate and industrial clients

B2C channels include:

  • Physical retail Stores shelves, in UAE and Germany.
  • Online marketplaces such as Amazon, Noon, and leading German e-commerce platforms
  • Direct-to-consumer sales via the official MEDUSA e-commerce website

MEDUSA SDP Wet Wipes

To support efficient global fulfillment, DHL has been selected for bulk and institutional shipments, while FedEx will manage retail and consumer-focused deliveries.

Looking ahead, the Company expects to begin regulatory approval processes for a bio-degradable, dissolving MEDUSA SDP wet wipes line, representing a breakthrough advancement in sustainable hygiene solutions and reinforcing CSDX’s long-term environmental strategy.

MEDUSA SDP Wet Wipes

“CS Group is focused on disciplined execution, strategic partnerships, and scalable growth,” Management stated. “MEDUSA SDP demonstrates how we translate innovation into commercially viable, globally relevant products while advancing sustainability.”

About CS Diagnostics Corp

CS Diagnostics Corp. (OTCQB: CSDX) is a medical technology company advancing a dual-focus platform across infection control and oncology, targeting high-priority global healthcare markets. The Company’s portfolio includes MEDUSA, a smart disinfectant and hygiene solutions platform expanding into wet wipes and liquid formulations for institutional and consumer use, and CS Protect-Hydrogel, a tissue spacer designed to protect healthy organs during prostate cancer radiotherapy. CSDX is progressing through key commercialization milestones, including strategic manufacturing partnerships, a multi-region launches across the GCC and Europe, diversified B2B and B2C distribution channels, global logistics agreements, and a growing intellectual property and regulatory roadmap. With plans to introduce biodegradable, dissolving hygiene products and expand internationally.

Forward-Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the timing and granting of regulatory and other third party consents and approvals, uncertainties regarding the Company’s or any third party’s ability to execute and implement future plans, and the occurrence of unexpected events.

Actual results achieved may vary from the information provided herein because of numerous known and unknown risks, uncertainties, and other factors.

For further information, please visit https://medusa-sdp.com/en/

or contact

Mohammad Essayed

Email: info@csdcorp.us

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92

https://www.globenewswire.com/NewsRoom/AttachmentNg/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c

https://www.globenewswire.com/NewsRoom/AttachmentNg/22a15a74-b111-4b35-8fca-b3f8252f17c1

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.